Chinese Congress Passes New Law Covering Product Liability For Drugs And Devices, Along With Medical Malpractice
This article was originally published in PharmAsia News
BEIJING - Chinese President Hu Jintao has signed an extensive new "Tort Law of the People's Republic of China" covering medical malpractice, product liability and related provisions that could affect companies across the life sciences with operations in China
You may also be interested in...
China's State FDA insists it will align the country's pharmaceutical and medical device regulations with international standards. The question on manufacturers' minds is, how soon
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).